All
Brolucizumab injection offers improved vision in neovascular age-related macular degeneration
September 11th 2021In a presentation at the EURETINA 2021 Virtual Congress, Cristina Cristian, MD, noted that an injection of brolucizumab treatment in patients with neovascular age-related macular degeneration led to a median improvement in visual acuity (VA) of 10.5 letters and the drug was well-tolerated.
Gene-independent therapeutic strategies for retinal degeneration include optogenetic therapy
September 10th 2021During a presentation at the EURETINA 2021 Virtual Congress, José-Alain Sahel, MD, explains that optogenetics involves the use of artificial photoreceptors from specific retinal cells to restore vision by transferring a gene that encodes for a light-sensitive protein that causes neuronal cells to respond to light stimulation.
Real-World Ophthalmology: A new conference to help ophthalmologists starting practice
September 9th 2021This conference titled, “The Top Ten Things I Wish I Knew Sooner,” is the brainchild of Lisa M. Nijm, MD, JD, who has had the foresight to help young ophthalmologists negotiate the choppy waters of a new practice.
Facing the challenges of treating peripheral hemorrhagic polypoidal choroidal vasculopathy
September 9th 2021Treating the disease can be a challenge, and at the EURETINA 2021 Virtual Congress, Chekitaan Singh, MD, discussed a case study detailing the care of a patient who had already lost vision in one eye from a similar issue.